.png){kind=icon}
.png){kind=icon}
Return
Early Safety and Feasibility Study of a Novel Transcatheter Aortic Valve With Polymeric Leaflets
.png){kind=icon}
PRE
AI
Z
Q
W
W
B
Y
H
D
X
L
S
Y
Z
R
H
Y
J
D
G
DOI：10.1016/j.jacasi.2025.10.032.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
BACKGROUND Transcatheter aortic valve replacement is a promising alternative treatment for patients with severe aortic stenosis (AS), but uncertainties remain regarding its long-term durability. OBJECTIVES This study aimed to evaluate the safety and feasibility of Sikelia transcatheter heart valve with polymeric leaflets in AS. METHODS In this first-in-human, prospective, nonrandomized, single-arm, multicenter study, patients with severe symptomatic AS eligible for the novel valve were recruited. Clinical outcomes and hemodynamic performance were reported at discharge and 30-day, 6-month, and 1-year follow-up. RESULTS Twelve patients (73.75 f 7.28 years, 25% female, mean Society of Thoracic Surgeons score 4.51% [4.07%-4.87%], 66.67% bicuspid valve) were enrolled. Procedural success was achieved in 83.33% (1 fully device retrieval and 1 death due to coronary obstruction). All patients successfully underwent transcatheter aortic valve replacement were in NYHA functional class I/II at the 30-day follow-up, and significant improvement was shown in 6-minute walk distance and Kansas City Cardiomyopathy Questionnaire score (all P < 0.001). At 1 year, the effective orifice area (2.31 f 0.33 cm2 vs 0.82 f 0.14 cm2) and mean pressure gradient (6.33 f 2.54 mm Hg vs 47.50 f 13.82 mm Hg) improved substantially, so did those in bicuspid patients (all P < 0.001). No moderate/severe paravalvular leakage was recorded, and computed tomography scans revealed no evidence of subclinical leaflet thrombosis during follow-up. After discharge, no patients reported death, stroke, new pacemakers, or valve-related reintervention. CONCLUSIONS The preliminary outcomes of the novel transcatheter heart valve demonstrated a favorable hemodynamic performance with an acceptable safety profile at 1 year. Long-term follow-up is warranted to assess its durability in treating patients with AS. (JACC Asia. 2026;6:465-473) (c) 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords:
aortic stenosis
polymeric leaflets
Sikelia
transcatheter heart valve
Journal
J
IF:
0
Papers:
148
Citations:
0
Organization
Cited Papers